Pierce will build and develop Ambu’s U.S. salesforce and launch the company’s endoscopic portfolio into the private clinc space for Urology and Otolaryngology.

Ambu Inc., a rapidly growing medical device maker and pioneer of sterile, single-use endoscopes, has named Matthew K. Pierce as its national sales director focusing on specialty clinics.

Pierce will build and develop Ambu’s U.S. salesforce and launch the company’s endoscopic portfolio into the private clinic sector for Urology and Otolaryngology.

“Matthew has an incredible track record of leading and developing nationwide sales groups and driving growth,” said Michael Masilonis, Vice President of Sales for Ambu Inc. “We see a significant opportunity for him and his team to quickly build our ENT and Urology single use endoscopy portfolios in the private clinic space.”

Prior to joining Ambu, Pierce was the national sales director at FERRING Pharmaceuticals where he was recruited to develop FERRING’s first Uro-Oncology division focused on advanced cancer treatments. He developed a robust field sales structured designed to exceed revenue targets of $500 million. Prior to Ferring, Pierce was executive director of sales at Dendreon Inc. and received the “Most Outstanding Leader Award” in 2017 as sales director across all business units. He was also regional sales director at Tolmar Pharmaceuticals overseeing a territory of eight states, Puerto Rico and the District of Columbia, and marketing manager at Ethicon Endo-Surgery.

Pierce received a Bachelor of Science and Arts degree in speech communications from the University of Southern Mississippi.

“Ambu recognizes that there is more than $200 million of procedural opportunity with our current laryngoscope and cystoscope platforms in private clinic and private ambulatory surgery centers and we are committed to ensuring that our products are at least present if not the main scope of choice for all ENTs and urologists who use flexible scopes,” Pierce said. “We believe specializing in this way will allow us to bring our cutting edge technology to doctors in their clinic procedures, and that we will be able to help them further enhance the experience for their patients, provide the best protection for both staff and patients, and better meet their workflow needs in today’s dynamic environment.”

Ambu launched the world’s first single-use flexible bronchoscope, the Ambu® aScope™ in 2009. Ten years later, in 2019, over 600,000 Ambu single-use endoscopes were used in more than 3,500 hospitals making Ambu the world’s largest supplier of single-use endoscopes.

About Ambu

Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring & diagnostics solutions. The manifestations of our efforts have ranged from early innovations like the Ambu® Bag™ resuscitator and the Ambu® BlueSensor™ electrodes to our newest landmark solutions like the Ambu® aScope™ – the world’s first single-use flexible endoscope. Moreover, we continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on the work of doctors, nurses and paramedics. Headquartered near Copenhagen in Denmark, Ambu employs approximately 3,000 people in Europe, North America and the Asia Pacific. For more information, please visit ambu.com or ambuUSA.com.